Alemtuzumab Intravenous and Carbocaine with Neo-Cobefrin
Determining the interaction of Alemtuzumab Intravenous and Carbocaine with Neo-Cobefrin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: levonordefrin / mepivacaine
Brand name: Carbocaine 2% with Neo-Cobefrin, Polocaine Dental, Scandonest 2% L
Synonyms: Mepivacaine and Levonordefrin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Carbofed DM
- Alemtuzumab Intravenous-Carbogen
- Alemtuzumab Intravenous-Carbon Dioxide Oxygen Mixture
- Alemtuzumab Intravenous-Carbonyl iron
- Alemtuzumab Intravenous-Carboplatin
- Alemtuzumab Intravenous-Carboplatin Intravenous
- Carbocaine with Neo-Cobefrin-Alenaze-D
- Carbocaine with Neo-Cobefrin-Alendronate
- Carbocaine with Neo-Cobefrin-Alendronate and cholecalciferol
- Carbocaine with Neo-Cobefrin-Alendronate Effervescent Tablets
- Carbocaine with Neo-Cobefrin-Alendronate Oral Solution
- Carbocaine with Neo-Cobefrin-Alendronate Sodium